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Abstract 
A commitment on quality objectives is a crucial element of quality policy in HROs, such as hospitals and other healthcare institutions. 
The quality of care includes objectives related to effectiveness, efficiency, and a patient’s experience. Healthcare organizations are also 
aware of the importance of promoting safety practices and the resiliency analysis of the clinical practice in order to improve quality. 
Patient Safety Culture has been defined as the product of individual and group values, attitudes, competencies, and patterns of behavior 
that determines their commitment, style, and proficiency with the organization’s health and safety programs. The safety culture of a 
health center offers an indirect means for its involvement in quality. Poor involvement of professionals in safety has negative 
consequences for patients. Envisioning the future of patient safety is more than an academic exercise. Appealing visions can help 
channel human energies, set new directions, and open the doors to alternative approaches. An outside observer is struck by three 
characteristics that are very different from the culture of the early 21st century: a deep sense of individual and institutional 
accountability for safety, an emphasis on fairness and transparency, and pervasive collaboration and teamwork based on mutual 
respect. Speaking up is important for patient safety, but healthcare professionals often hesitate to voice their concerns. Direct 
supervisors have an important role in influencing speaking up. However, good insight into the relationship between managers' behavior 
and employees' perceptions about whether speaking up is safe and worthwhile is still lacking. The evaluation should cover the following 
areas in both instruments: strategy (inquiry on their commitment to the quality and safety strategy, indicators’ feedback, and risks 
maps), support systems for clinical decisions (digital record algorithms to make decisions and for accessibility to patient clinical 
information), equipment (adequacy), follow-up (availability of tests when needed), person-centered care (respect of patients’ values 
and preferences), evidence-based practice (practices in accordance with guidelines), delays (on scheduled tests, surgery, and outpatient 
care), and cost-effective treatments (adequacy). 
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Introduction 
Medicines are the commonest medical interventions used in 
health care and safe use is important. Over the past 20 years, a 
number of initiatives aimed at improving medication safety 
have been introduced into hospitals. The IOM estimated costs 
due to medical errors in the US of was approximately $37.6 
billion/year. About $17 billion of it are associated with 
preventable errors. Clinicians, policymakers and patients now 
want to know whether progress has been made and where 
further improvement may be required. In 2016, medical errors 
were estimated to result in 250 000 deaths annually, making  
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medical errors the third leading cause of death in the USA. 
Drug-related errors are the most common type of medical error 
and can result from discrepancies in patient medications during 
periods of transition of care. Around 60% of medication errors 
occur during patient admission, discharge or transfer of care. It 
is estimated that at least one medication error occurs each day 
for an average hospitalized patient. Err offered a similar 
conclusion relative to safety: flaws are unacceptable and 
common. The effective remedy is not to browbeat the health 
care workforce by asking them to try harder to give safe care, 
when in fact, the courage, hard work, and commitment of 
health care workers are the only real means to stem the tide of 
errors latent in the health care system. Growth in knowledge 
and technologies has never been so profound and prolific. 
However, research on the quality of care demonstrates that the 
health care system falls short in its ability to translate 
knowledge to practice and to apply new technologies safely and 
appropriately. These principles health care organizations could 
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take now or as soon as possible to substantially improve patient 
safety include (1) providing leadership; (2) respecting human 
limits in process design; (3) promoting effective team 
functioning; (4) anticipating the unexpected; and (5) creating a 
learning environment. 
 
1.1. Important Definitions 
Active Error: Active errors are those taking place between a 
person and an aspect of a larger system at the point of contact. 
Active errors are made by people on the front line such as 
clinicians and nurses. For example, operating on the wrong eye 
or amputating the wrong leg are classic examples of an active 
error. 
 
Adverse Event: Adverse events may be preventable when there 
is a failure to follow accepted practice at a system or individual 
level. An adverse event attributable to an error usually is a 
preventable adverse event. 
 
Latent Error: These are errors in system or process design, 
faulty installation or maintenance of equipment, or ineffective 
organizational structure. These are present, but may go 
unnoticed for a long time with no ill effect. 
 
Medical Error (ME): The failure to complete the intended plan 
of action or implementing the wrong plan to achieve an aim. An 
unintended act or one that fails to achieve the intended 
outcome. 
 
Negligence: Failure to meet the reasonably expected standard 
of care of an average, qualified healthcare worker looking after 
a patient in question within similar circumstances. For example, 
the healthcare worker may not check up on the pathology 
report which led to a missed cancer or the surgeon may have 
injured a nerve by mistaking it for an artery. 
 
Negligent Adverse Events: A subcategory of preventable, 
adverse events that satisfy the legal criteria used in determining 
negligence. The injury caused by substandard medical 
management. 
 
Near Miss: Any event that could have had an adverse patient 
consequence but did not. Near misses provide opportunities for 
developing preventive strategies and actions and should 
receive the same level of scrutiny as adverse events. 
 
Noxious Episode: Untoward events, complications, and 
mishaps that result from acceptable diagnostic or therapeutic 
measures deliberately instituted. For example, sending a 
hemodynamically unstable trauma patient for prolonged 
imaging studies instead of the operating room.  The result could 
be a traumatic arrest and death. 
 
Patient Safety: The process of amelioration, avoidance, and 
prevention of adverse injuries or outcomes that arise as a result 
of the healthcare process [1]. 
1.2. Scope of Safety Problems 
The provision of high-quality, affordable, health care services is 
an increasingly difficult challenge. Due to the complexities of 
health care services and systems, investigating and interpreting 
the use, costs, quality, accessibility, delivery, organization, 
financing, and outcomes of health care services is key to 
informing government officials, insurers, providers, consumers, 
and others making decisions about health-related issues. 
Appropriate medication use is a complex process involving 
multiple organizations and professions from various disciplines 
combined with a working knowledge of medications, access to 
accurate and complete patient information and integration of 
interrelated decisions over a period of time. The growing 
complexity of science and technology requires health care 
providers to know more, manage more, monitor more, and 
involve more care providers than ever before. Current methods 
of organizing and delivering care are not able to meet the new 
expectations of patients and families because the knowledge, 
skills, care options, devices, and medications have advanced 
more rapidly than the health care system’s ability to deliver 
them safety, effectively, and efficiently. The potential for errors 
of omission or commission to creep into the process is 
extraordinary. Workflow analysis has often been used with the 
goal of improving efficiency. As primary care differs from 
hospital care in several important ways, e.g. in-patient 
characteristics, organizational structure, relationships between 
health-care professionals and patients and types and outcomes 
of patient-safety incidents, the risks associated with hospital-
based care should not be assumed to be the same as those 
associated with primary care. In response to financial pressure 
and incentives driving provider organizations, minimizing slack 
time has become important [2], [3].  
 
2. Understanding Error 
Clinicians’ fears of lawsuits and their self-perceptions of 
incompetence could be dispelled by organizational cultures 
emphasizing safety rather than blame. To understand what is 
or is not known about medication related adverse events, 
common definitions must be established and understood. 
Organizations must come to a common understanding 
regarding MEs, reporting requirements, and risks to capture 
and act upon error potential within their own medication use 
systems. The potential benefits of intra-institutional and Web-
based databases might assist pharmacists and other providers 
to prevent similar hazards and improve patient safety [4]. These 
definitions of ADE, PADE, ADR provide the following insights 
regarding adverse events and medication use: 
 
 MEs are considered preventable while adverse drug 
reactions are generally are not. 
 If an error occurs, but is intercepted by someone in the 
process, it might not result in an adverse event. These 
potential adverse events are often referred to as near 
misses. 
 Capturing information regarding near misses could 
yield vital information regarding system performance. 
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3. Identifying Risk 
Two approaches to the problem of human fallibility are 
possible: the individual and the system approach. The individual 
approach focuses on the errors of individuals, blaming them for 
forgetfulness, carelessness or moral weakness. The system 
approach concentrates on the conditions under which 
individuals work and tries to build defenses to avert errors or 
mitigate their effects. Health care professionals are human and 
can make mistakes. Reporting an error is often viewed as 
professional failure or negligence and is followed by sanction or 
punishment of the individuals involved. Medications are 
inherently toxic, and there is a risk to taking them and, perhaps, 
not taking them. Each time a practitioner prescribes a product, 
a treatment risk versus benefit must be assessed. If a patient 
takes prescribed medications in a different manner than 
prescribed or if over-the-counter products and alternative 
agents are added, there are additional risks. Side effects and 
tragic rare reactions are also difficult to anticipate. This results 
in health care workers worrying constantly about the ever-
present reality of error. Unfortunately, in many organizations, 
the response to error targets the people rather than the system 
involved in the production of an error [3], [5]. Reason has 
identified that there are a variety of defenses put into systems 
to provide the following functions: 
 
 Create understanding or awareness of hazards 
 Give guidance on how to operate safely 
 Provide alarms and warnings when risk or danger is 
evident 
 Place barriers between hazards and individuals or 
other systems 
 Restore system to a safe state when conditions are not 
normal 
 Contain or eliminated hazards if the barrier is not 
adequate 
 Establish methods of escape and rescue should hazard 
containment fail  
 
4. Targeting Medication Safety at The Microsystem Level 
Nelson and colleagues suggest that understanding and 
nurturing clinical microsystems (Table 1) may create an 
opportunity for leverage toward the goal of a safety and more 
effective health care system [6]. 
 
Table 1. Scope of Ten Success Characteristics, Underlying Principles, and Safety Impact 
Scope of Success Characteristic  Underlying Principle  Safety Impact 
Leadership 
 Maintain constancy of purpose 
 Establish clear goals/expectations 
 Foster positive culture 
 Advocacy with in macro 
organization 
 Formal, informal, on-the-spot 
Leader balances setting and reaching 
collective goals with empowering 
individual autonomy and accountability 
 Define safety vision 
 Identify constraints for safety 
improvement 
 Allocate resources for plan development, 
implementation, monitoring and 
evaluation 
 Build input of microsystem to plan 
development 
 Align quality and safety goals 
 Provide update to Board of Trustees 
Organizational support 
 Recognition, resources, information 
 Enhance and legitimize work of 
microsystem 
Larger organization finds ways to connect 
and facilitate work of microsystem, 
including coordination and handoffs 
between Microsystems 
 Work with clinical Microsystems to 
identify patient safety issues and make 
relevant local changes 
 Put the necessary resources and tools into 
the hands of individuals without making it 
superficial 
Staff focus 
 Selective hiring 
 Integration into culture and roles 
 Aligning work with training 
competencies 
 High expectations for performance, 
continuing education, professional 
growth, networking 
Human resource value chain that links 
microsystem’s vision with real people 
for hiring, orienting, continuously 
educating, retraining and providing 
incentives 
 Assess current safety culture 
 Identify gap between current culture and 
 safety vision 
 Plan cultural interventions 
 Conduct periodic assessments of culture 
Education and training 
 Ongoing education 
 Organizational learning 
 Work roles and competencies 
aligned 
 Best use of people and resources 
Team approaches to training create 
learning that is collaborative and focused 
on quality, safety and integrated into 
work flow 
 Develop patient safety curriculum 
 Provide training and education of key 
clinical and management leadership 
 Develop a core of people with patient 
safety skills who can work across 
microsystems as a resource 
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Interdependence of care team 
 Trust 
 Collaboration 
 Willingness to help others 
 Appreciation of complimentary roles 
 Recognition of inputs to shared 
purpose 
Multidisciplinary team provides care and 
every person is respected for individual 
vital role 
 Build PDSA into debriefings 
 Use daily huddles for AARs and celebrate 
identifying errors 
Patient focus 
 Caring 
 Listening 
 Educating 
 Response to special requests 
 Innovating 
 Providing smooth service flow 
 Relationship with community 
resources 
The patient is the common focal point, 
it’s why we’re all here 
 Establish patient and family partnerships 
 Support disclosure and truth about 
medical error 
Community and market focus 
 Partnership with community for 
resource exchange 
 Outreach 
 Innovation and excellence 
Resource exchange and information 
sharing to assure that patient needs are 
met 
Analyze safety issues in community and 
partner with external groups to reduce risk 
to population 
Performance patterns 
 Patient outcomes 
 Cost avoidance 
 Streamlined delivery 
 Data feedback 
 Positive competition 
 Open dialog about performance 
Outcomes are routinely measured, with 
feedback to Microsystems leading to 
change based on data 
 Develop key safety measures 
 Create the “business case” for safety 
Process improvement 
 Learning and redesign focus 
 Continuous care monitoring 
 Benchmarking 
 Tests of change 
 Staff empowered to innovate 
Studying, measuring and improving care 
are essential elements of daily work 
 Identify patient safety priorities based on 
assessment of key safety measures 
 Address the work that will be required at 
the microsystem level 
 Establish patient safety “demonstration 
sites” 
 Transfer the learning 
Information and IT 
 Information is key 
 Technology links information and 
care 
 Communication and channels 
Information is a connector designed to 
support work of the unit for the right 
information at the right time 
 Enhance error reporting system 
 Build safety concepts into information 
flow (e.g. checklists, reminder systems, 
etc) 
 
 
5. Collaboration Across the Medication Use Process 
Collaboration is essential to minimize patient risk in the 
medication use process. Health care providers within the 
organization need to understand and identify how these 
components function and who is involved in making these steps 
safe. Clear understanding of the critical safety issues at each 
one of these steps are of particular importance because the 
primary goal of adverse event identification is adverse event 
prevention. Each step can be considered a risk point and 
provides opportunities for internal checks and balances. At 
each step in the medication use process, it is often assumed 
physicians, nurses, pharmacists, and other health care 
providers in the organization play a role in patient evaluation 
[7]. This evaluation would include assessing patient 
characteristics, medication selection, concurrent medications, 
medication dosage selection, and medication administration 
methods appropriate for the condition to be treated. The 
current system of prescribing, dispensing, administering, and 
monitoring, however, often places the responsibility on the 
individual to avoid making the mistake [8], [9]. Because this 
expectation seems unreasonable, organizations should focus 
efforts to improve medication use safety by using a systems-
based approach that identifies: 
 
 Errors that occur most frequently 
 Possible root causes of errors 
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 Error prevention strategies to make it harder for the 
same or similar errors to occur 
 If the organization has a system that makes it harder 
to commit an error, it will be more difficult for 
 
6. System Failures in the Medication Use Process 
Varieties of systems failures have been identified in hospitals 
that have studied factors associated with adverse events [3]. 
These system failures are listed below: 
 
• Deficiencies in medication knowledge, including 
prescribing of incorrect medications, doses, forms, 
frequency, or routes of administration 
• Failure to verify the identity or dose of medication 
administered, often due to look-alike packaging or 
similarities between medication names 
• Inaccessibility of patient information including 
laboratory test results, current medications, and 
information on the patient’s current condition 
• Incorrect transcription of orders, often due to 
illegibility of the physician’s handwriting 
• Failure to note known medication allergies 
• Inefficient order tracking, making it difficult to 
determine when a medication has been given, 
missed/discontinued or changed 
• Poor communication between services, including 
between nurses and pharmacists 
• Improper use of administration devices 
• Lack of standardized dosing schedules or disregard of 
existing standards 
• Lack of standardized system for medication 
distribution 
• Lack of standardized procedure across units 
• Errors in preparation of intravenous medications 
(when performed in the patient care area) 
• Poor information transfer when patients are moved 
from one patient care area to another 
• Inadequate or nonexistent system for resolving 
conflicts related to medication orders 
• Deficiencies in staffing or work assignments leading to 
excessive workloads, inconsistent availability of staff 
or inadequate management 
• Lack of feedback and follow-up information on 
observed adverse drug events 
 
 
 
 
 
 
 
 
 
 
 
7. Classification of Medication Errors 
Medication errors can occur in: 
 
 Choosing a medicine—irrational, inappropriate, and 
ineffective prescribing, under-prescribing and 
overprescribing;  
 Writing the prescription—prescription errors, 
including illegibility;  
 Manufacturing the formulation to be used—wrong 
strength, contaminants or adulterants, wrong or 
misleading packaging; 
 Dispensing the formulation—wrong drug, wrong 
formulation, wrong label; 
 Administering or taking the drug—wrong dose, wrong 
route, wrong frequency, wrong duration; 
 Monitoring therapy—failing to alter therapy when 
required, erroneous alteration. 
 
The best way to understand how medication errors happen and 
how to prevent them is to consider their classification, which 
can be contextual, modal, or psychological. Contextual 
classification deals with the specific time, place, medicines, and 
people involved. Modal classification examines the ways in 
which errors occur (e.g. by omission, repetition, or 
substitution). However, classification based on psychological 
theory is to be preferred, as it explains events rather than 
merely describing them. Its disadvantage is that it concentrates 
on human rather than systems sources of errors. These 
classifications have been discussed in detail elsewhere [10], 
[11]. Mistakes can be divided into (i) knowledge-based errors 
and (ii) rule-based errors. Failures of skill can be divided into (iii) 
action-based errors ('slips', including technical errors) and (iv) 
memory-based errors (‘lapses’). Knowledge-based errors can 
be related to any type of knowledge, general, specific, or 
expert. It is general knowledge that penicillin’s can cause 
allergic reactions; knowing that your patient is allergic to 
penicillin is specific knowledge; knowing that co-fluampicil 
contains penicillins is expert knowledge. Ignorance of any of 
these facts could lead to a knowledge-based error. Rule-based 
errors can further be categorized as (a) the misapplication of a 
good rule or the failure to apply a good rule; and (b) the 
application of a bad rule. An action-based error is defined as 
‘the performance of an action that was not what was intended’. 
A slip of the pen, when a doctor intends to write diltiazem but 
writes diazepam, is an example. Technical errors form a subset 
of action-based errors. They have been defined as occurring 
when ‘an outcome fails to occur or the wrong outcome is 
produced because the execution of an action was imperfect’. 
An example is the addition to an infusion bottle of the wrong 
amount of drug. Memory-based errors occur when something 
is forgotten; for example, giving penicillin, knowing the patient 
to be allergic, but forgetting [12-14]. 
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Figure 1: The classification of medication errors based on a psychological approach [11] 
 
 
8. Medication Error-Prevention Strategies 
To decrease the occurrence of medication errors, it is important 
to work toward developing strategies to combat the risk of 
medication errors at all steps in the medication-use process.  
 
 Elimination of handwritten medical records and 
physician orders/ Computerized provider-order entry 
systems 
 Institute fail-safe tracking of medications and 
laboratory tests to ensure that patients receive correct 
medications and tests on time 
 Automated dispensing cabinets 
 Implement bar-coding 
 Establish protocols and guidelines that outline 
standardized practices 
 Provide all medications in unit dose packaging, ready 
for patient administration 
 Standardize medication procedures such as protocols 
for the use of hazardous medications, medication 
terminology, and medication names 
 Make it difficult for someone to do something wrong 
by error proofing 
 Medication reconciliation 
 Make relevant patient information available at the 
point of patient care 
 CME 
 Emergency-medicine clinical pharmacists 
 Improve the patient’s knowledge about treatment [3], 
[15] 
 
 
 
9. Recommendations for Prescribing Improvements 
The prescribing stage is one of the stages where medication 
errors occur most frequently, representing 71% of serious 
medication errors in hospital emergency. These errors occur 
when the physician orders the wrong drug, wrong dose, a drug 
to which a patient is allergic, or duplication in therapy. The 
nurse may then perpetuate the error by not questioning the 
physician. In addition, handwritten prescriptions can lead to 
catastrophic results, due to sloppy handwriting and confusion 
about decimal points. Many opportunities exist to improve the 
safety of the medication use process. The prescribing phase of 
the medication use process, however, encompasses the 
majority of medication errors that result in preventable ADEs.  
The most common drug group involved in MEs in Medicine 
ward was antibacterial followed by GI group, CVS group and IV 
fluids. This could be because a significant number of patients 
were hospitalized due to infectious diseases and CVS diseases. 
Presence of potential significant and serious DDIs in the 
prescriptions from Medicine and Pediatric ward. Potential 
significant DDIs were more common with CVS drugs such as 
atenolol, enalapril, digoxin, and furosemide. The risk of DDI was 
significant due to multiple drug therapy along with co-
morbidities in patients more than 40 years of age. While GI 
drugs such as ranitidine and ondansetron have been prescribed 
inappropriately, anticipating gastritis and vomiting in these 
patients. Prescribing of medications outside the accepted 
medical standards is known as an inappropriate prescribing. 
However, there were few irrational prescriptions (31%) with 
unnecessary drugs such as ondansetron, ranitidine, 
multivitamins, folic acid, ceftriaxone, and metronidazole. The 
knowledge that ADEs can be prevented compels organizations 
to identify the factors or system failures that contribute to the 
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errors in the prescribing phase. Such factors identified in the 
prescribing phase include: 
 
• Availability of medication information at time of 
prescribing 
• Access to patient information at time of prescribing 
• Availability of dosing information at time of 
prescribing 
• Availability of allergy information at time of 
prescribing 
• Accuracy or completeness of order by prescriber 
• Legibility of handwriting 
• Use of abbreviations 
• Use of decimals in expressions of weight and measure 
• Use of varied units of measure 
• SALAD [3], [17], [20] 
 
10. Error Potential in the Dispensing Phase 
The key player at this stage is the pharmacist. An example of 
the former type was a study in a UK hospital in which the 
researchers used semi-structured interviews of pharmacy staff 
about self-reported dispensing errors. The most common 
causes mentioned were: being busy (21%), being short-staffed 
(12%), being subject to time constraints (11%), fatigue of 
healthcare providers (11%), interruptions during dispensing 
(9.4%), and SALAD (8.5%). The dispensing process has both 
mechanical and judgmental components. This is alarming as 
infants (<1 year) are vulnerable population for medicine AEs 
such as wrong dose, wrong route of administration, or use of 
off-label drugs. In addition, pharmacokinetic or 
pharmacodynamic of drugs also differ in this patient 
population. A study in Saudi Arabia showed 47.3% overdose 
errors. IV fluid administration is involved with wrong rates 
worldwide. The reason for inaccurate dose administration is 
due to poor communication between health care professional 
team, missed labeling of IV fluid, and improper use of 
instruments. As a result, prevention of dispensing errors will 
require a comprehensive approach including evaluation of: 
 
• Work environment: workload, distractions, physical 
location of service, hours of operation 
• Inventory management: outdated or unused products, 
look-alikes, sound- alike, clutter, labeling, purchasing of 
unit of use products 
• Information resources: available references, updates, 
consultants, computer or decision support technology 
• Performance evaluation: evaluation of staff competency 
and practice skill, knowledge and behaviors, cross-
checking redundancies 
• Patient involvement: patient education and review with 
show and tell techniques 
 
 
 
Several critical steps have been advocated for improving 
dispensing accuracy: 
 
• Secure or sequester high-risk medications 
• Develop and implement standardized storage 
procedures 
• Reduce distraction potential and improve workflow 
in dispensing environment 
• Use reminders (labels, computer alerts) to prevent 
SALAD mix-ups 
• Keep prescription order, label, medication and the 
medication container together throughout 
dispensing process 
• Perform a final check on prescription content 
including verification with original prescription 
order and label 
• Enter a manufacturer identification code into the 
computer profile and on prescription label 
• Perform a final check on the prescription label, if 
possible, using automation such as bar-coding 
• Provide patient counseling [16], [17], [20] 
 
11. Error Potential in the Transcribing Phase 
Entering incorrect data onto the medication administration 
record by nonmedical personnel can be a factor. Transcription 
errors occur when a communication issue occurs between the 
prescriber and the individual dispensing or administering the 
medication. These can develop from handwriting errors, but 
can also be secondary to unclear or misinterpreted orders. The 
uniqueness of transcribing errors lies in the fact that they are 
due to communication failures rather than knowledge 
opportunities; they are 100% preventable. The use of CPOE 
systems can essentially eliminate the occurrence of these errors 
by having providers enter medication orders directly into the 
system. Some contributing factors to these errors include the 
multitude of names, dosage forms, and strengths of various 
agents. Soundalike medications and abbreviations also provide 
a significant obstacle to eliminating these errors as well [15], 
[17]. 
 
12. Error Potential in the Administration Phase 
The act of physically administering the drug to the patient 
represents the very last moment providers can catch errors 
before they can do harm. Nurses are absolutely critical 
personnel at this stage. These errors typically arise when the 
wrong drug is administered, or the right drug is administered in 
the wrong dose, via the wrong route, or with an incompatible 
co-administered drug. These errors encompass the wrong drug, 
the wrong patient, and the wrong route. A common error in 
hospitals involves patient-controlled analgesia pumps. 
Although the advantage of the pump is the ability of the patient 
to obtain the right dose, if the pump has not been programmed 
correctly the patient may risk serious side effects. Busy 
schedule, urge to complete work as early as possible, and 
missing double check/cross checking of prescription orders can 
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lead to wrong route of administration. These reasons not only 
increase the patient risk, but also increase the cost of 
treatment. The administration phase, serves as a last final check 
on processing the entire medication order itself and includes: 
 
 Evaluating the written order for appropriateness and 
completeness 
 Assuring appropriate indication for use 
 Evaluating and interpreting use of terminology and order 
method (abbreviation, units of measure, use of verbal 
orders) 
 Dosing calculation or verification 
 Identification of the patient 
 Timing of treatment in context of other therapies 
 Preparation and possibly dispensing of medication 
 Proper use of medication devices 
 Patient education 
 Documentation of treatment [3], [15], [17], [20] 
 
13. Errors during patient discharge and monitoring 
Medication errors are a common and significant problem, 
particularly when patients transition between healthcare 
providers. Discrepancies are especially prevalent on hospital 
admission and discharge. As patients move between health 
providers and settings, discrepancies and miscommunication in 
clinical records are common and lead to serious medication 
errors. Hospital admissions and discharges, interdepartmental 
transfers, or care shared between a specialist and a GP, are 
often dangerous times for patients, especially those with long-
term conditions or taking multiple medicines. The percent of 
patients with one or more medication discrepancy at hospital 
discharge has been reported at 14% to more than 30% in 
different research. Of the errors discovered at hospital 
discharge in a prospective observational study, more than 50% 
had the potential to result in moderate to severe harm. 
Recommendations to avoid medication errors during and after 
patient discharge include a medication discussion with the 
patient featuring open-ended questioning and active listening 
to effectively share information, patient education focused on 
medications such as insulin administration, and providing the 
patient with an accurate list of medications to be taken after 
discharge. The monitoring stage involves the activities following 
administration of a medication and observing the impact of 
pharmacotherapy. This is not only within the traditional sense 
of monitoring on the inpatient side but also includes patients 
discharged to home and ensuring that appropriate follow-up 
occurs. Poor medication management during or immediately 
after hospital admission increased the risk of readmission in the 
next month by 28%. The key to reducing serious medication 
errors and patient harm is to ensure timely, accurate handover 
of medicines at all transition points in care. Smooth transitions 
require competent and coordinated responses from health 
professionals focused on the individual’s needs. Implementing 
medication review by a pharmacist at hospital admission and 
creating a discharge medication reconciliation form and report 
that patients can take home with them reduced medication 
errors from nearly 60% to 30%. More than half of Canadians 
(55%) and Americans are estimated to have less than adequate 
health literacy skills. It is important that patients are given 
adequate discharge instructions and are counseled on potential 
self-monitoring techniques, as well as any possible harmful side 
effects that may occur [20-25].  
 
14. Changing Systems Within Organizations 
Within the United Kingdom of Great Britain and Northern 
Ireland, for example, there are about 100 000 reports of 
patient-safety incidents from England and Wales every month. 
Real and potential ME in inpatients can be identified mainly 
reviewing drug prescriptions by the pharmacists. The most of 
interventions are focused in wrong anti-infective dosages. 
Prevention strategies for ME deriving from analyses of the 
reports are contributing directly to patient safety. Health 
institutions, which are known to be complex organizations, 
have over the years devised improvement strategies and added 
quality to the health care service. Patient's safety culture 
reflects the perceptions of processes, norms, and attitudes 
relating to a culture of preventable errors shared by health 
professionals in the delivery of care. In health environments, 
behaviors and attitudes shape the culture of each organization. 
The sharing of beliefs, values, and attitudes related to the 
patient's safety culture influences the outcome and 
organizational aspects. Quality in hospital services means 
providing the patient with multidisciplinary care at minimal risk. 
Therefore, implementing improvements in organizational and 
safety culture enhances quality. Among the validated tools, the 
HSOPS and the SAQ, both created in the USA, are widely cited 
in research that aims to assess the safety culture of patients in 
different countries. The culture of safety is measured by the 
staff perspective. For each dimension, percentages above 75% 
are considered as strengths and below 50% are areas that need 
improvement. The following items have routinely been 
identified as a top 10 list for improvement in general: 
 
 Improving knowledge about medications (availability, 
access and timeliness) 
 Dose/identity tracking of medications (process 
understanding of distribution) 
 Available patient information (availability, access, 
accuracy and timeliness) 
 Order transcription (elimination of process) 
 Allergy defense (hard stop capabilities, access to patient 
information) 
 Medication order tracking (streamlining and effective 
communication of patient needs) 
 Communication (patient information, system 
performance, medication use) 
 Device use (standardization and competency regarding 
use) 
 Standardization of medication dose 
 Standardization of medication distribution [3], [19], [26, 
27] 
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Exhibit 1. WHO’s International Classification for Patient Safety: descriptions of harm severity [28] 
None Outcome was not symptomatic or no symptoms were detected and no treatment was required. 
Mild Patient outcome was symptomatic, symptoms were mild, loss of function or harm was either minimal 
or intermediate but short-term and no intervention or only a minimal intervention, e.g. extra 
observation, investigation, review or minor treatment, was required. 
Moderate Patient outcome was symptomatic, required more than a minimal intervention, e.g. additional 
operative procedure or additional therapeutic treatment, and/or an increased length of stay and/or 
caused permanent or long-term harm or loss of function. 
Severe Patient outcome was symptomatic, required a life-saving or other major medical/surgical 
intervention, shortened life expectancy and/or caused major permanent or long-term harm or loss of 
function. 
Death On balance of probabilities, death was caused or brought forward in the short-term by the incident. 
 
 
15. Conduction of a Root Cause Analysis 
DDIs account 6–30% of all adverse drug events and can increase 
occurrences of ME. Furthermore, self-medication, poor 
communications between the prescriber and the patient, and 
even demand of the patient for medicine for each symptom, 
unethical drug promotion and inducements increases irrational 
prescribing. Medication-error reporting is an essential aspect of 
limiting medication-error occurrence and the development of 
medication error-prevention strategies. Despite the profound 
impact that these errors have on the system, they largely go 
underreported, mainly due to the fear of repercussions. 
Although challenging, medication errors should be viewed as 
valuable learning exercises to improve care and limit their 
recurrence, and hospital management should avoid taking 
punitive action against individuals involved in medication 
errors, as this discourages reporting and limits learning 
opportunities. Every medication error that goes unreported 
represents an error that will continue to be replicated and 
continue to put patients at risk. Errors that are reported allow 
for the development of potential countermeasures to either 
eliminate them altogether or mitigate their impact. The large 
majority of errors are the result of defects that exist within the 
underlying systems of practice rather than within human 
practitioners, as they merely serve as the vessel by which these 
shortcomings are manifested. One population that is 
particularly vulnerable are patients admitted to the ICU. ICU 
patients have a combination of rapidly changing medical 
conditions, laboratory values, and medications, which present 
a particular challenge for clinicians in practice in every aspect of 
patient care. Medication errors can occur in different phases 
(prescribing, distribution, administration, and monitoring) of 
the medication process and have a significant impact on 
morbidity and mortality. Medication error analysis requires a 
structured approach including: detection, reporting, and 
analysis, in order to provide the most efficient and practical 
information to the ICU team. In addition, a particular focus is 
made on the implementation of medication error prevention 
strategies such as evidenced-based protocols, team education, 
and technology. In an effort to reduce medication error rates in 
the ICU requires a collaborative, multi-disciplinary approach in 
order to be effective and consistent through time. Although the 
elimination of medication errors should be the goal of any 
organization, it is important to recognize that the occurrence of 
medication errors is an inevitable part of clinical practice. There 
are several key features for health care organizations to 
consider as the conduct a root cause analysis: 
 
 Identify a multidisciplinary team to assess the error, 
failure, or adverse event of interest 
 Establish a way to communicate findings and data 
elements required to conduct the analysis 
 Create a plan with target dates, responsibilities, and 
measurement/data collection strategies required for 
the investigation 
 Define all elements of the process and issues clearly 
 Brainstorm all possible causes or potential causes 
 Identify interrelationships of causes or potential 
causes 
 Sort, analyze and prioritize cause list 
 Determine which processes and systems are part of 
the investigation 
 Determine special and common causes 
 Begin the design and implementation of the change 
while engaging in the root cause analysis 
 Repeat each of the steps listed previously as 
appropriate 
 Focus on being thorough (Ask why) and credible (Be 
consistent, dig deep, and leave no stone unturned!) 
 Target system improvement, particularly the larger 
systems 
 Redesign to eliminate root cause(s) 
 Measure and assess new design [3], [15], [18] 
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Exhibit 2. Primary Care Harm Severity Classification System [27] 
Severity Definition Examples 
No harm Any incident that ran to completion but no harm occurred to 
the patient 
Patient received azathioprine but missed routine 
hematological monitoring for several months. No 
harm incurred 
No harm 
outcome 
due to 
mitigating 
action 
Any incident that had the potential to cause harm to a patient 
but resulted in no harm 
A receptionist issued an incorrect prescription that 
indicated a patient should take one tablet twice daily 
instead of once daily. The chemist providing the 
tablets, who had dispensed to the patient previously, 
noted the error and corrected the regimen 
Mild harm Incident in which: (i) patient was harmed, with mild and short-
term impact, on physical, mental or social functioning, that 
was expected to resolve in a few hours; (ii) patient was 
harmed but required no or minimal intervention/treatment, 
e.g. anti-emetic, oral antibiotic or repeat of a minor procedure 
such as vaccination or insertion of contraceptive implant; 
and/or (iii) patient or their loved ones experienced transient 
emotional distress but no long-term consequences and 
incident report contains words, e.g. angry, anxious, confused, 
distressed, frightened, frustrated, humiliated or upset, that 
might describe a feeling that occurs at the time of the incident 
but soon passes 
An on-call primary-care physician prescribed oral 
analgesic for a patient who could not swallow. A 
second physician also made a prescription error, 
leaving patient in pain for three hours. 
Moderate 
harm 
Incident in which: (i) patient was harmed, causing a medium-
term impact on physical, mental or social functioning that was 
expected to resolve in days; (ii) patient required medical 
intervention in the form of treatment, e.g. antibiotics or 
intravenous fluids; (iii) patient required short-term 
hospitalization for assessment and/or minor treatment in 
either ED or a hospital ward; and/or (iv) patient or their loved 
ones experienced psychological difficulty of a more 
longstanding nature but not requiring formal treatment, e.g. 
as indicated by evidence in the report of more longstanding 
anxiety, insomnia, or low mood 
A patient was prescribed amoxicillin despite being 
known to have penicillin allergy. Although the error 
was corrected and the patient given clarithromycin, 
the patient claimed to have lost trust in doctors and 
to be extremely anxious about taking the 
clarithromycin 
Severe 
harm 
Incident in which: (i) patient was harmed, causing a major 
long-term or permanent impact on physical, mental or social 
function or shortening of life-expectancy; (ii) patient was 
harmed and required major medical or surgical intervention 
that, most often, was delivered in a hospital setting, e.g. 
cardioversion, any major surgery; (iii) patient was harmed and 
required prolonged hospitalization or admission to CCU, HDU 
and/or ICU; and/or (iv) patient or their loved ones 
experienced enduring psychological difficulty that required 
specialist treatment, e.g. as indicated in the report by 
evidence of chronic anxiety or depression or psychosis 
An epileptic child who had been prescribed 
phenobarbital was admitted with symptoms of 
drowsiness and had decreased tone for three days. 
He was ventilated and immediately transferred to 
the ITU because he had a low GCS score. His blood 
concentration of phenobarbital was found to be 
abnormally high. When the patient’s own supply of 
phenobarbital was checked, the original 
manufacturer’s label gave the strength as 25 mg/mL 
but the erroneous community pharmacy’s label 
indicated 25 mg/5 mL. The child had been receiving 
five times the prescribed dose 
Death Incident in which, on the balance of probabilities, death of the 
patient was caused or brought forward in the short term by 
the incident 
A patient contacted an out-of-hours service by 
telephone, reporting feeling unwell, vomiting and a 
rash on his stomach. A physician, who returned the 
patient’s call, diagnosed a viral illness and asked the 
patient to make arrangements for a relative to collect 
a prescription for an anti-emetic. Within 90 minutes, 
however, the patient had deteriorated and been 
brought to the ED of his hospital. The patient was 
diagnosed with meningococcal septicemia and died 
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Insufficient 
detail 
Incident for which the report carries insufficient information 
to evaluate the severity of harm. The report may describe an 
error or outcome that was not the result of primary health 
care, e.g. a fall in the waiting room. Alternatively, it may fail 
to describe any outcome or it may describe a patient-safety 
incident but give insufficient information to classify the 
severity of harm of the outcome, e.g. it may record a delay in 
getting an appointment but not describe the consequences of 
the delay for the patient 
A patient provided samples for histology and 
cytology, but the provider collecting the samples in 
specimen pots forgot to label the pots 
* ED: emergency department; CCU: coronary care unit; GCS: Glasgow coma scale; HDU: high dependency unit; ICU: intensive care 
unit; ITU: intensive therapy unit. 
 
 
16. Sources of Learning About Patient Safety 
 The Agency for Healthcare Research and Quality 
(AHRQ) 
 The American Hospital Association (AHA) 
 Anesthesia Patient Safety Foundation (APSF) 
 Annenberg Patient Safety Conferences 
 Institute for Healthcare Improvement (IHI) 
 Institute for Safe Medication Practices (ISMP) 
 Joint Commission on Accreditation of 
 Healthcare Organizations (Joint Commission, 
JCAHO) 
 Leapfrog Group 
 Malcolm Baldrige National Quality Program 
 Massachusetts Coalition for the Prevention of 
Medical Errors 
 Minnesota Hospital and Healthcare Partnership 
(MHHP) 
 National Academy for State Health Policy (NASHP) 
 National Coalition on Health Care (NCHC) 
 National Committee for Quality Assurance (NCQA) 
 National Patient Safety Foundation (NPSF) 
 National Quality Forum (NQF) 
 United States Pharmacopeial Convention (USP) 
[29] 
 
17. Role of Patients in Medication Errors 
This area is relatively under-researched and there remain 
several unanswered questions. Little is known about how 
patients understand drug related problems or how they make 
attributions of adverse effects. Some research suggests that 
patients' cognitive models of adverse drug reactions bear a 
close relationship to models of illness perception. Recent NICE 
guidelines recommend that professionals should ask patients if 
they have any concerns about their medicines, and this 
approach is likely to yield information conducive to the 
identification of medication errors [30].  
 
 
 
 
 
 
18. Developing a medication communication framework 
Communication breakdown, collaboration failure, and inability 
to recognize the clinical deterioration of patients are the main 
reasons for the occurrence of serious events in the hospital 
setting. Sharing patient-specific health care information during 
handoff requires situational awareness. In the hospital setting, 
most of the communication related to patient care occurs 
between nurses, pharmacists and physicians. Challenges of 
communication among health care providers are not limited to 
differences in training and reporting expectations. The 
estimated rate of preventable ADEs, caused by medication 
errors, is 1.5 million per year in the US. There is a link between 
medication errors and medication communication; 
communication between providers and between providers and 
patients, within and across care settings, have been identified 
as sources of medication error. The Joint Commission, AHRQ, 
IHI, and WHO recognize SBAR as an effective communication 
tool for patients’ handoff. SBAR is a reliable and validated 
communication tool which has shown a reduction in adverse 
events in a hospital setting, improvement in communication 
among health care providers, and promotion of patient safety. 
Despite its importance, communication is often an embedded 
component (not the focus) of models that explore medication 
management workflow, including describing: medicine 
pathways; e-prescribing; and patient safety [31,32]. 
 
 
Exhibit 3. Components for achieving continuity in 
medication management across the continuum of care 
outlined by APAC [33]. 
 Decision to prescribe medicine  
 Record of medicine order/prescription  
 Review of medicine order/prescription 
 Issue of medicine  
 Provision of medicine information 
 Distribution and storage  
 Administration of medicine  
 Monitor for response 
 Transfer of verified information 
 
 
 
Commentary PHARMACY PRACTICE 
 
http://z.umn.edu/INNOVATIONS                         2019, Vol. 10, No. 1, Article 6                       INNOVATIONS in pharmacy 
                                                                             DOI: https://doi.org/10.24926/iip.v10i1.1637 
12 
 
Medication management requires extensive collaboration and 
communication across roles and care settings, which can 
reduce (or contribute to) medication-related errors. 
Medication management involves key recurrent activities: 
determine need; prescribe; dispense; administer; and 
monitor/evaluate with information communicated within and 
between each activity; medication communication is therefore 
embedded within the framework. Coordinating activities 
include: relaying messages between care providers and relaying 
messages between patients and care providers; requesting or  
 
transmitting patient information for current or historical 
medication records; requesting and confirming appointments 
and referrals; and requesting, confirming, or alerting roles of 
the status of medication coverage. While the content of what 
these roles communicate falls within other medication 
communication activities (e.g., prescribing, dispensing, 
monitoring), their responsibility is to facilitate the coordination 
of this information between roles (e.g., between a family 
physician and a pharmacist) [34]. 
 
 
 
 
Figure 2: Medication communication framework (Source:  
BMC Health Services Research 201313:418 https://doi.org/10.1186/1472-6963-13-418) 
 
 
 
While the five medication management categories (determine 
need, prescribe, dispense, administer, monitor/evaluate) had 
alignment with communication activities, not all 
communication activities could be mapped directly to the 
medication management framework. The medication 
communication activities are mapped along pathways between 
roles. Interestingly, fewer coordinate communication pathways 
observed in the integrated clinic versus the non-integrated  
 
 
 
clinics. In a non-integrated clinic, the pharmacy is off-site and 
coordination is regularly required to link the family physician 
and pharmacist together to confirm, for instance, current 
medications as reflected in the electronic provincial medication 
repository or to discuss a dispensing alert (e.g., for a 
contraindicated medication). In the integrated clinic with a 
pharmacy on-site, however, conversations between the 
pharmacist and family physician generally occur directly in the 
pharmacy or clinic hallway [34]. 
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Exhibit 4. Important definitions regarding Medication communication [33] 
 Determine need involves communication around activities to determine the need for medication, e.g., a doctor 
and patient discussing the patient’s complaint; 
 Prescribe focuses on communication around prescribing activities, e.g., a patient and doctor discussing the 
details of a new prescription; 
 Dispense focuses on communication around dispensing activities, e.g., a pharmacist and physician resolving 
an alert for a duplicate medication; 
 Administer involves communication around medication administration activities, e.g., a pharmacist and 
patient discussing medication administration instructions; 
 Monitor/Evaluate focuses on communication around medication monitoring and evaluation, e.g., a patient 
and Home and Community Care nurse discussing medication compliance. The monitor/evaluate activity was 
often used to inform the other medication communication activities for medication decision-making; and 
 Coordinate communication focuses on the coordination of medication information between roles, e.g., a MOA 
transmitting a request for information between a pharmacist and a family physician. 
 
Currently, the “gold standard” of obtaining the best possible 
medication history involves a pharmacist compiling patient 
history, obtaining patient and office medication lists, pharmacy 
data, and discharge summaries upon admission. Approaching 
discharge, the pharmacist reviews changes in medications, 
describes indications and reviews discontinued medications. 
Post discharge, the pharmacist contacts the patient again to 
resolve any unanswered questions. Many institutions are not 
yet current with these best practices or have limited pharmacy 
staff to complete such tasks. The process of medication 
reconciliation is then delegated to nurses or physicians who 
often do not have time or resources to ensure a high-degree of 
accuracy. Although this workflow is effective for a single 
hospitalization, it is a laborious task that must be repeated at 
every transition of care and does not address the issue of 
creating multiple out-of-date medication lists. Medication 
reconciliation is a Joint Commission National Patient Safety 
Goal and a core measure of Stage 2 meaningful use. However, 
hospitals and EMR vendors have struggled to meet this 
mandate. [33-37]. 
 
Exhibit 5. Suggested interventions to address health communication and participation [38-40] 
 Training for health professionals and health services personnel, in how to: 
o Better involve patients and carers in their individual care. 
o Communicate with patients and carers, particularly people from diverse cultural and linguistic 
backgrounds. 
o Involve consumers and carers in the health service more broadly. 
 Cultural change activities for hospitals and health professionals. 
 Electronic health records (accessible by patients and carers). 
 Support for patients and family members to negotiate healthcare services, for example, patient advocates in 
hospital or peer support workers. 
 Better information for general public, patients and family members, including written and online formats that 
are easy to read, standardized and present risks and harms. 
 Community education campaigns about when and how to access health services and understanding key health 
concepts. 
 Training for researchers and consumers in how to involve consumers in research and share research findings 
in understandable ways. 
 
Collaboration with groups of health professionals other than 
nurses remains relatively unexplored. Due to the large volume 
of work published on collaboration with nurses, we focused on 
the other actors within the primary care team. Pharmacist-
provided direct patient care has been quantitatively assessed 
as effective on safety and patient-based outcomes, including 
medication adherence, patient knowledge and health-related 
quality of life. In addition, pharmacist–physician quality circles 
in ambulatory care are cost-effective. Counseling in primary 
care can be associated with significantly greater clinical 
effectiveness in short-term mental health outcomes compared 
with usual care and cause a significant reduction in the number 
of consultations, prescriptions and referrals to specialist care. It 
is likely that professionals' beliefs and values are determining 
factors for collaboration, as it is a complex process beyond the 
efficacy of some experimentation. Continuity is achieved 
through the interactions across the patient’s circle of care. 
Communication must be part of the care and the cure. If 
patients do not have the tools, they need to understand their 
disease, engage in shared decision making, and manage their 
health, including following appropriate health guidance, then 
the intended benefits of medical care and medicines can be 
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compromised—or wasted altogether. It is up to all of us in the 
health community to make improving health literacy part of our 
calling. It is therefore necessary to better understand actors' 
perceptions before implementing shared roles and 
responsibilities between professional groups [39-45]. 
 
Conclusion 
The path to safer medication use and improvements in patient 
safety is not about a destination. This is a journey that must 
involve iterative learning. There are no absolute solutions, no 
mystical pronouncements that will tell the profession of 
pharmacy what to do to fix the system. The problems it faces 
will not be solved by the level of thinking that created them. 
The profession is forced to consider new approaches, new 
knowledge and to consider ways of thinking, acting and being 
that are outside our traditional approaches. Ultimately, the 
judge of the quality of work, the services delivered and the 
outcomes of care is an increasingly well-informed patient, as 
well as their payors and regulators from the public and private 
sectors. Focus on patient needs and wants, less on how we do 
it around here. 
 
 
 
Article Highlights:  
1. Around 60% of medication errors occur during patient admission, discharge or transfer of care. 
2. Medication errors are considered preventable while ADRs are not 
3. Reporting an error is often viewed as professional failure or negligence and is followed by sanction or punishment of the 
individuals involved. 
4. Collaboration is essential to minimize patient risk in the medication use process. 
5. Staff shortage, interruption and SALAD comprises around 30% errors in the dispensing phase. 
6. In 2016, medical errors were estimated to result in 250 000 deaths annually, making medical errors the third leading cause 
of death in the USA. 
7. Medication errors can take place at any stage of choosing a medicine, writing the prescription, manufacturing the 
formulation, dispensing, administration and monitoring therapy. 
8. UAE bans handwritten medical prescriptions due to 7,000 deaths worldwide result from illegible handwriting 
9. 50% of US population receives prescription annually and estimates ‘inappropriate’ prescriptions in doctor’s office setting at 
up to 30%. 
10. The NHS makes hundreds of millions of prescribing errors and mix-ups, leads to 22,300 deaths a year UK, according to a major 
report commissioned by the Government. 
11. Unfortunately, in many organizations, the response to error targets the people rather than the system involved in the 
production of an error. 
12. The IOM estimated costs due to medical errors in the US of was approximately $37.6 billion/year. About $17 billion of it are 
associated with preventable errors. 
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